Soy-Ready to Use Therapeutic Food (RUTF) in Severely Malnourished Children

NCT01634009 | Completed Phase 2 DMC

• 1 other identifier: PR-09038
• Study Type: interventional
• Target: 260
• Locations: 1 country
• Sites: 1

Brief Summary

SAM defined by having weight-for-height (WH) less than - 3 Z score or bi-pedal nutritional edema is an important cause of death in children globally including Bangladesh. The death rate among children hospitalized for SAM is still high. Severe malnutrition in children can be successfully treated by using WHO guidelines with or without minor modification. Since the Community Based Therapeutic Care (CTC)/CMAM approach was developed, the use of RUTF for the treatment of children with SAM has gained ground, and huge amounts of RUTF are used particularly in African countries. RUTFs are an energy-dense lipid paste enriched with vitamins and minerals. The typical composition (ingredient % of weight) of RUTF is whole milk powder 30%; sugar 28%; vegetable oil 15.4%; peanut paste 25%; and mineral vitamin mix 1.6%. Although the CTC model promises treatment of SAM at a considerably lower cost than the previous inpatient model, the cost of RUTF is still considered a significant barrier to universal roll-out of SAM treatment and has made CTC implementation too expensive in many high-need countries. The single most expensive raw ingredient in RUTF is milk powder, contributing around 50% of raw ingredient cost or between 30-35% of the total cost of the final product. Isolated soy protein has a cost per kg protein that normally is below that of skim or whole milk powder, and can thus reduce the total cost of RUTF. In addition, isolated soy protein (ISP) is a high quality, complete protein that meets the daily protein requirements of growing children and adults. ISP is a highly digestible protein \[FAO/WHO, 1991\] with an amino acid profile that has been shown to achieve a Protein Digestibility-Corrected Amino Acid Score (PDCAAS) of 1.00, comparable to milk and eggs, and has been shown to maintain nitrogen balance when fed as the sole protein source at minimum recommended intake levels. To compare the efficacy (weight gain, rate of weight gain and change of lean body mass) of the standard RUTF and an RUTF made from ISP (Soy-RUTF) through a randomized double masked intervention trial 300 SAM children aged 6 to 59 months after completion of their stabilization phase from the Dhaka Hospital of icddr,b Bangladesh will be studied. They will randomly receive standard- or Soy-RUTF as take home and followed up (weekly until achieving -2 WHZ, and thereafter fortnightly until achieving -1 WHZ) at the nutrition follow up unit at the outpatient department of this Dhaka Hospital of icddr,b.

Conditions

Severe Acute Malnutrition; Severe Wasting; Community Based Nutritional Management

Keywords

Severe acute malnutrition; Ready to use therapeutic food; Soy protein; Community based management; Efficacy; Management of Children with SAM in Bangladesh

Outcome Measures

Primary Outcomes (1)

• To compare the efficacy (rate of weight gain)

  By 31st December 2014 we shall be able to complete the enrollment, data analyses and preliminary/draft report writting.

  31 December 2014 (up to 3 years)

Study Arms (2)

Standard RUTF (control)

ACTIVE COMPARATOR

Children will receive standard RUTF in this arm and will be considered as control arm

Dietary Supplement: Soy-based RUTF (in double blind design)

Standard RUTF

NO INTERVENTION

Will act as control

Interventions

Soy-based RUTF (in double blind design) DIETARY_SUPPLEMENT

Soy-based RUTF will be given in double blind manner

Also known as: Soy-based RUTF is the intervention

Standard RUTF (control)

Eligibility Criteria

• Age: 6 Months - 5 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)

You may qualify if:

• children (both boys and girls) with SAM defined by WH \< -3 Z score of WHO standard,
• completed acute (stabilization) phase management,
• clinically well,
• no edema and regaining appetite and aged 6 to 60 months will be included. - additional enrollment criteria will be as follows:
• no signs of concurrent infection,
• mothers/caregivers agreed to stay in their current address for next 4 months (for tracking the children)

You may not qualify if:

• failure to obtain consent from parents or caretakers;
• children without any fixed address;
• children with tuberculosis or any congenital/acquired disorder affecting growth i.e. trisomy-21 or cerebral palsy;
• having history of soy, peanut or milk protein allergy.

Sponsors & Collaborators

• International Centre for Diarrhoeal Disease Research, Bangladesh: lead

Study Sites (1)

Icddr,B

Dhaka, 21212, Bangladesh

Location

Related Publications (1)

• Hossain MI, Huq S, Islam MM, Ahmed T. Acceptability and efficacy of ready-to-use therapeutic food using soy protein isolate in under-5 children suffering from severe acute malnutrition in Bangladesh: a double-blind randomized non-inferiority trial. Eur J Nutr. 2020 Apr;59(3):1149-1161. doi: 10.1007/s00394-019-01975-w. Epub 2019 Apr 29.

  PMID: 31037340 DERIVED

MeSH Terms

Conditions

Severe Acute Malnutrition; Cachexia

Condition Hierarchy (Ancestors)

Malnutrition; Nutrition Disorders; Nutritional and Metabolic Diseases; Weight Loss; Body Weight Changes; Body Weight; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Thinness

Study Officials

• MD IQBAL HOSSAIN, DCH, PhD

  International Centre for Diarrhoeal Disease Research, Bangladesh

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: phase 2
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: PARTICIPANT, CARE PROVIDER, INVESTIGATOR
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 12, 2012
• First Posted: July 6, 2012
• Study Start: July 1, 2012
• Primary Completion: December 1, 2016
• Study Completion: December 1, 2016
• Last Updated: September 25, 2017

Record last verified: 2016-06

Locations

BA (1)